NCT07020819Phase 3Recruiting

An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

Study sponsor: Annexon, Inc. · ANNX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-05-31Estimated
Enrollment · participants30Estimated
Source updated2026-10-26Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: 31 Dec 2026. After: 31 May 2027.

Check registry source

· 2 fields changed

Primary completion date changed

Before: Dec 2026. After: 31 Dec 2026.

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source